• Home
  • Journal Information
    • For Reviewers
    • Human and Animal Rights
    • Journal office
    • Open Access
    • Publication Ethics and Malpractice Statement
    • Publisher
    • Founder & Chairman
  • Guidelines
    • Informed Consent
    • Peer Review Process
    • Checklist for Review
    • AUTHORS’ AGREEMENT FORM
  • Create Account
  • Login
   
Search
 eISSN: 2423-8015  
Submit Your Paper For AuthorsAims and ScopeEditorial BoardPublication EthicsEditorial policies Archive

Indexed in


Follower of


Committee on Publication Ethics (COPE) Flowchart 


Recommendations for the Conduct


COPE: Reviewers


World Association of Medical Editors(WAME)


EQUATOR Resources: Reviewers

  July 2019, Vol 5, No. 2
Immunopathologia Persa
July 2019, Vol 5, No. 2
Original

1. Protective effect of aliskiren against renal ischemia reperfusion via antioxidant property and nitric oxide signaling pathway

Leila Mohmoodnia ORCiD, Sahar Koushki, Michele Moruzzi, Sajad Papi, Reza Mohammadrezaei Khorramabadi ORCiD, Behrooz Farzan ORCiD, Babak Hadian ORCiD, Amin Hasanvand* ORCiD
Immunopathol Persa. 2019;5(1):e10-e10. doi: 10.15171/ipp.2019.10
Abstract
PDF
XML
Cited By:
Protective effect of aliskiren against renal ischemia reperfusion via antioxidant property and nitric oxide signaling pathway
Immunopathol Persa. 2019;5(1):e10-e10. doi: 10.15171/ipp.2019.10

Original

2. Antioxidative and anti-inflammatory impact of valsartan against renal ischemia-reperfusion injury; role of nitric oxide signaling pathway

Leila Mohmoodnia ORCiD, Sarina Safari Ahmadvand, Sahar Koushki, Behrooz Farzan ORCiD, Sajad Papi, Babak Hadian ORCiD, Ahmad-Reza Dehpour ORCiD, Amin Hasanvand* ORCiD
Immunopathol Persa. 2019;5(2):e19-e19. doi: 10.15171/ipp.2019.19
Abstract
PDF
XML
Cited By:
Antioxidative and anti-inflammatory impact of valsartan against renal ischemia-reperfusion injury; role of nitric oxide signaling pathway
Immunopathol Persa. 2019;5(2):e19-e19. doi: 10.15171/ipp.2019.19

Paper Press
© 2018 The Author(s). This work is licensed under a Creative Commons Attribution 4.0 License.

Powered by




© Copyright 2010-2018 MAAD-Rayan ICT Inc. All rights reserved.
Paper Press (Ppress) v.1.2.1

Designed by:
MAAD-Rayan ICT.

Advisors:
Omidi Y
Omidi AA

All rights reserved.
Email: khosravi.r@gmail.com
MAAD-Rayan ICT Inc.